The Board has appointed a Remuneration Committee to prepare recommendations for the remuneration and other terms of employment for the CEO and other senior executives who together make up the Executive Management. The principles for remuneration to senior executives are resolved on by the AGM. The Remuneration Committee prepares its recommendations based on these principles.
Born in 1949. Board Vice Chairman. Elected to the Board in 2003. BioGaia Board Chairman 2007–2018. MBA from the Stockholm School of Economics. Marketing and PR consultant. President of Innoventive Partners LLC. Former Executive Vice President and Marketing Director at Philip Morris USA and Philip Morris International. Other board assignments: New York City Ballet Inc., School of Creative Leadership, Berlin University and Swedish-American Chamber of Commerce (chairman 1997–2001). Holds 875,000 class B shares.
Born in 1980. Elected to the Board in 2015. Holds a bachelor’s degree in Management and Systems from City, University of London and a master’s degree in Financial Management from the University of Cape Town. Former Chief Operating Officer Fund Linked Products at Credit Suisse Investment Bank, London. Other board assignments: Infant Bacterial Therapeutics AB (IBT). Holds 16,000 class B shares.
Born 1963. Board Chairman. He has extensive and solid experience as a CEO in the food ingredients sector, as well as leadership roles within the nutrition and health sectors. He served as President and CEO of Chr. Hansen A/S from 2018 to 2024, and as President of the Flavour Division at Givaudan AG from 2006 to 2018, having previously held other leading positions within Givaudan. Mauricio Graber is a member of the Board of Directors and Deputy Chairman of the Board of Directors of Jungbunzlauer Holding AG, holds Board assignments in Barry Callebaut AG and AM SILK GmbH, and is a member of the Advisory Board of Novo Holdings A/S. Holds 735,754 class B shares.
The Board of Directors is responsible for the company’s organization and the administration of the company’s affairs.
The task of the Nominating Committee is to prepare recommendations regarding election and remuneration for decision by the AGM.
The task of the external auditor is to examine BioGaia’s annual accounts and accounting practices, as well as to review the Board and the CEO’s management of the company.